The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Within Europe, plants in Germany and the Netherlands are affected. Infomation on plants in other European countries wll follow.
Sector
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
3,000 jobs Number of planned job losses
Announcement Date
21 September 2010
Employment effect (start)
Foreseen end date
30 September 2012
Description
The pharmaceutical company Abbott Laboratories intends to reduce its global workforce by 3,000, with most of the jobs losses due to take place across Europe. The company has already announced 500 job losses at its factory in Weesp (Netherlands) and 300 jobs in Hannover (Germany) with more European job reductions yet to be announced.
Most of the jobs losses will occur in the units previously owned by the pharmaceutical division of Solvay, acquired by Abbott. Following this take-over Abbott is now streamlining its operations and this includes job reductions in divisions such as marketing, R&D, sales and production.
The restructuring plan includes the closure of a Solvay facility in Marietta, Georgia (USA), by the end of 2011, Ms. Brotz said.
In addition, the work force at Solvay sites in Hannover, Germany, and Weesp, the Netherlands, will be scaled back.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
